GINN Focal Person
Joel Rubenstein brings over 25 years of leadership in the health, wellness, and consumer healthcare sectors, with proven success across CPG, prescription (Rx), and over-the-counter (OTC) categories. He has held US and global marketing roles at Pfizer, Novartis, and GlaxoSmithKline, and served in general management positions at Niconovum AB (Sweden) and Aspeya Healthcare (Denmark), where he was Global Vice President driving smoking cessation brand and category growth in competitive markets. From launching innovative nicotine products to advancing sustainability initiatives and building high-performing commercial teams, Joel delivers results through pragmatic strategy, cross-functional leadership, and a consumer-first approach. A strong advocate for science-driven innovation, he is committed to giving consumers better choices to help them thrive.
